Improved adjuvant theraphy of G250-expressing tumors

Improved adjuvant theraphy of G250-expressing tumors

  • CN 101,052,416 A
  • Filed: 06/29/2005
  • Published: 10/10/2007
  • Est. Priority Date: 07/02/2004
  • Status: Active Grant
First Claim
Patent Images

1. the antigenic method for cancer of G250 is expressed in treatment, it comprises the G250 antigen-specific antibodies or/and its antibody fragment delivers medicine to the patient of primary tumo(u)r as auxiliary treatment, and wherein the patient carried out the excision of primary tumo(u)r and carried out lymph node resection in case of necessity and/or should carry out the primary tumo(u)r excision and carry out lymph node resection in case of necessity.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×